Should we routinely use mupirocin to prevent staphylococcal infections?

Virginia R. Roth*, Cathryn Murphy, Trish M. Perl, Alfred DeMaria, Annette H. Sohn, Ronda L. Sinkowitz-Cochran, William R. Jarvis

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)


Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.

Original languageEnglish
Article number04423
Pages (from-to)745-749
Number of pages5
JournalInfection Control and Hospital Epidemiology
Issue number11
Publication statusPublished - 1 Jan 2000
Externally publishedYes


Dive into the research topics of 'Should we routinely use mupirocin to prevent staphylococcal infections?'. Together they form a unique fingerprint.

Cite this